Chameleon Communications International
James Serginson has a diverse work experience spanning over the years. James started their career as a Lab Assistant at Chemetall PLC, where they worked on chemical development for automotive and aerospace industries. Following this, they worked as a Research Associate at Imperial College London, leading a polymer synthesis project. James then pursued freelance work as a Medical Editor, where they provided editing and rewriting services for technical manuscripts. James later joined Niche Science & Technology as a Medical Writer before transitioning to Chameleon Communications International, where they served in various roles including Medical Writer, Senior Medical Writer, Principal Medical Writer, and currently, as the Senior Scientific Director for Experimental Communications.
James Serginson completed their education at Imperial College London. From 2003 to 2007, they pursued an MSci degree in Chemistry. Subsequently, they pursued a Doctor of Philosophy (PhD) degree in Chemistry from 2007 to 2011.
This person is not in any offices
Chameleon Communications International
Chameleon Communications has a 25 year heritage as a ground-breaking, entrepreneurial global medical communications agency partner. Driven by our philosophy to improve the lives of patients worldwide by positively changing the way medicine is practiced. People are our focus. We invest in and empower our people to provide the best talent in the industry. We build progressive internal collaborations and valued partnerships with our pharma clients to achieve the extraordinary together. We harness our collective (brain) power with 250+ experienced, dedicated experts across the globe, collaborating to bring inspiring intelligence to the development and execution of scientific and marketing communications. We are a member the Healthcare Consultancy Group (HCG) and part of Omnicom Health Group (OHG).
Industries
Employees
201-500